Discover
ADGM
Adagio Medical Holdings, Inc.
0.66
5 x 0.75
1 x 0.68
bid
ask
+
0.01
1.44%
3 @ 05:25 AM
0.63 -0.03 (4.67%)
| Ytd | -36.44% | |
| 1y | -51.04% |
0.65
day range
0.68
0.62
52 week range
2.58
| Open | 0.68 | Prev Close | 0.65 | Low | 0.65 | High | 0.68 | Mkt Cap | 14.68M |
| Vol | 1.42K | Avg Vol | 141.16K | EPS | -1.32 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.10 | Short Ratio | 0.85 | Inst. Own | 91.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.87 | 200-d Avg | 1.11 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 5.20M | ||
| Research and Development Expense | 2.74M | ||
| Selling, General and Administrative Expense | 2.46M | ||
| Operating Income | -5.20M | ||
| Interest Expense | 778.00K | ||
| Net Income | -6.99M | ||
| Net Income Common Stock | -6.99M | ||
| Net Income Common Stock (USD) | -6.99M | ||
| Consolidated Income | -6.99M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -6.22M | ||
| Earning Before Interest & Taxes (USD) | -6.22M | ||
| Weighted Average Shares | 22.21M | ||
| Weighted Average Shares Diluted | 22.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.91M | ||
| Cash and Equivalents (USD) | 12.91M | ||
| Current Assets | 15.86M | ||
| Property, Plant & Equipment Net | 2.52M | ||
| Total Assets | 39.31M | ||
| Debt Current | 225.00K | ||
| Total Debt | 24.09M | ||
| Current Liabilities | 8.57M | ||
| Debt Non-Current | 23.86M | ||
| Total Liabilities | 33.58M | ||
| Accumulated Retained Earnings (Deficit) | -102.63M | ||
| Accumulated Other Comprehensive Income | -143.00K | ||
| Shareholders Equity | 5.73M | ||
| Shareholders Equity (USD) | 5.73M | ||
| Assets Non-Current | 23.45M | ||
| Total Debt (USD) | 24.09M | ||
| Goodwill and Intangible Assets | 20.94M | ||
| Inventory | 1.60M | ||
| Liabilities Non-Current | 25.01M | ||
| Trade and Non-Trade Payables | 1.22M | ||
| Tax Liabilities | 883.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 210.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.20M | ||
| Capital Expenditure | -2.00K | ||
| Net Cash Flow from Investing | -2.00K | ||
| Net Cash Flow from Operations | -4.13M | ||
| Effect of Exchange Rate Changes on Cash | -68.00K | ||
| Share Based Compensation | 389.00K | ||